Tengs T O, Adams M E, Pliskin J S, Safran D G, Siegel J E, Weinstein M C, Graham J D
Center for Health Policy Research and Education, Duke University, Durham, North Carolina 27708, USA.
Risk Anal. 1995 Jun;15(3):369-90. doi: 10.1111/j.1539-6924.1995.tb00330.x.
We gathered information on the cost-effectiveness of life-saving interventions in the United States from publicly available economic analyses. "Life-saving interventions" were defined as any behavioral and/or technological strategy that reduces the probability of premature death among a specified target population. We defined cost-effectiveness as the net resource costs of an intervention per year of life saved. To improve the comparability of cost-effectiveness ratios arrived at with diverse methods, we established fixed definitional goals and revised published estimates, when necessary and feasible, to meet these goals. The 587 interventions identified ranged from those that save more resources than they cost, to those costing more than 10 billion dollars per year of life saved. Overall, the median intervention costs $42,000 per life-year saved. The median medical intervention cost $19,000/life-year; injury reduction $48,000/life-year; and toxin control $2,800,000/life-year. Cost/life-year ratios and bibliographic references for more than 500 life-saving interventions are provided.
我们从公开的经济分析中收集了美国救生干预措施成本效益的相关信息。“救生干预措施”被定义为任何能够降低特定目标人群过早死亡概率的行为和/或技术策略。我们将成本效益定义为每挽救一年生命的干预措施的净资源成本。为提高通过不同方法得出的成本效益比率的可比性，我们设定了固定的定义目标，并在必要且可行时修订已发表的估计值以实现这些目标。所确定的587项干预措施范围广泛，从节省的资源超过成本的措施，到每挽救一年生命成本超过100亿美元的措施。总体而言，每项挽救生命年的干预措施成本中位数为42,000美元。医疗干预措施的成本中位数为19,000美元/生命年；减少伤害为48,000美元/生命年；毒素控制为2,800,000美元/生命年。提供了500多项救生干预措施的成本/生命年比率及参考文献。
